The abstract, titled Development and validation of an AI-enabled prediction of prostate cancer (PCa) using urine-based liquid biopsy (Abstract #3080), has been accepted for presentation in the poster ...

REHOVOT, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech ... today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic ...

April 30, 2025--(BUSINESS WIRE)--PanGIA Biotech, a company advancing urine ... 3080), has been accepted for presentation in the poster session titled Developmental Therapeutics—Molecularly ...